info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Stem Cell Banking Market Research Report Information By Cell Type (Umbilical Cord Stem Cells, Adult Stem Cells, Embryonic Stem Cells), By Bank Type (Private Banks, Public Banks, Hybrid Banks) and By Application (Thalassemia, Cerebral Palsy, Diabetes, Leukemia, Autism), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/HC/6969-HCR | 90 Pages | Author: Kinjoll Dey| November 2024

Market Segmentation


Stem Cell Banking Cell Type Outlook (USD Billion, 2018-2032)




  • Umbilical Cord Stem Cells




  • Adult Stem Cells




  • Embryonic Stem Cells




Stem Cell Banking Bank Type Outlook (USD Billion, 2018-2032)




  • Private Banks




  • Public Banks




  • Hybrid Banks




Stem Cell Banking Application Outlook (USD Billion, 2018-2032)




  • Thalassemia




  • Cerebral Palsy




  • Diabetes




  • Leukemia




  • Autism




Stem Cell Banking Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • North America Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • North America Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • US Outlook (USD Billion, 2018-2032)




    • US Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • US Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • US Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • CANADA Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • CANADA Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • Europe Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • Europe Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • Germany Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • Germany Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • France Outlook (USD Billion, 2018-2032)




    • France Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • France Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • France Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • UK Outlook (USD Billion, 2018-2032)




    • UK Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • UK Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • UK Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • ITALY Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • ITALY Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • Spain Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • Spain Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • Rest Of Europe Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • Rest Of Europe Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • Asia-Pacific Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • Asia-Pacific Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • China Outlook (USD Billion, 2018-2032)




    • China Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • China Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • China Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • Japan Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • Japan Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • India Outlook (USD Billion, 2018-2032)




    • India Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • India Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • India Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • Australia Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • Australia Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • Rest of Asia-Pacific Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • Rest of Asia-Pacific Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • Rest of the World Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • Rest of the World Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • Middle East Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • Middle East Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • Africa Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • Africa Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Stem Cell Banking by Cell Type




      • Umbilical Cord Stem Cells




      • Adult Stem Cells




      • Embryonic Stem Cells






    • Latin America Stem Cell Banking by Bank Type




      • Private Banks




      • Public Banks




      • Hybrid Banks






    • Latin America Stem Cell Banking by Application




      • Thalassemia




      • Cerebral Palsy




      • Diabetes




      • Leukemia




      • Autism







Research Methodology on Stem Cell Banking Market


Introduction


The global stem cell banking market is expected to record robust growth over the forecast period 2023-2030. This is owing to the increased usage of stem cells in a wide range of applications such as regenerative medicine, drug discovery, personalized medicine and the study of disease-causing genes. The market players contributing to the growth are engaged in establishing a wider base of customers as well as broadening their product offerings. Companies are also investing extensively in research and development activities to further enhance the capabilities of their stem cell banks.


Research Objective


The overall objective of this research is to understand the current status of the stem cell banking market (in terms of market trends, current market drivers, market size, competitive landscape and prospects) and forecast its growth till 2030.


Research Methodology


The research is conducted by using various primary and secondary sources of data. The primary sources of data for this project would be interviews with key industry players and surveys on various stem cell banking professionals, such as executives, researchers, developers, nurses, etc. A survey was conducted to provide individual perspectives on the stem cell banking market that would not be typically available in published literature. The secondary sources of data include various published reports and journals and websites of key industry players. Furthermore, extensive market knowledge and key insights into the stem cell banking industry were obtained by industry experts through informal conversations.


Data Collection


Primary data was primarily collected through extensive interviews with key industry experts such as Stem Cell Banking Professionals (Heads, Executives, Researchers, Nurses, Developers, etc.) and surveys on various stem cell banking professionals, such as executives, researchers, developers, nurses, etc. The survey was aimed towards collecting individual perspectives on the stem cell banking market that would not be typically available in published literature. The objective of the survey was to study the industry trends and market conditions that are influencing market growth.


Secondary data was collected by extensive review and analysis of published reports and journals related to stem cell banking. Secondary sources also include websites of key industry players, relevant databases such as Hoovers, Bloomberg, Business Market Insights, and government resources. Data collected from secondary sources were used to supplement the primary data collected by providing the overall market and industry landscape. This data was further validated by cross-checking with industry experts through informal conversations for confirming its accuracy.


Data Analysis


The research process has followed the quantitative approach in analysing the data. Data from the surveys, primary interviews and secondary sources have been tabulated to find meaningful insights. Regression analysis was used to map the data to get key findings on the market size. These findings were validated and triangulated with the industry experts from the informal discussions to ensure the accuracy of the results.


Conclusion


The overall research objectives of this project are to gain a comprehensive understanding of the stem cell banking market (in terms of market trends, current market drivers, market size, competitive landscape and prospects) and forecast its growth till 2030. Primary and secondary data sources were used to gain insights into the current status of the market. Data collected from surveys and interviews with key industry personnel and experts were analysed using regression analysis. Further, discussions with industry experts were used to validate and confirm the results of the analyses. This is expected to provide a comprehensive understanding of the stem cell banking market and enable the formulation of strategies by the key players to gain a competitive edge in the market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Stem Cell Banking Market, by Cell Type

1.1.2. Global Stem Cell Banking Market, by Bank Type

1.1.3. Global Stem Cell Banking Market, by Application

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.5. Breakdown of Primary Respondents

3.6. Forecasting Techniques

3.7. Research Methodology for Market Size Estimation

3.8. Bottom-Up Approach

3.9. Top-Down Approach

3.10. Data Triangulation

3.11. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

6. GLOBAL STEM CELL BANKING MARKET, BY CELL TYPE

6.1. Overview

6.2. Umbilical Cord Stem Cells

6.2.1. Cord Blood

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Cord Tissue

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Placenta

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Adult Stem Cells

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Embryonic Stem Cells

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL STEM CELL BANKING MARKET, BY BANK TYPE

7.1. Overview

7.2. Private Banks

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Public Banks

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Hybrid Banks

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL STEM CELL BANKING MARKET, BY APPLICATION

8.1. Overview

8.2. Thalassemia

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Cerebral Palsy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Diabetes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5. Leukemia

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6. Autism

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.7. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL STEM CELL BANKING MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitor Dashboard

10.3. Major Growth Strategies in the Stem Cell Banking Market

10.4. Competitive Benchmarking

10.5. The Leading Players in terms of Number of Developments in the Stem Cell Banking Market

10.6. Key Developments & Growth Strategies

10.7. Major Market Players Financial Matrix & Market Ratio

11. COMPANY PROFILES

11.1. CBR Systems, Inc.

11.1.1. Company Overview

11.1.2. Products/Services Offered

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Cryo-Cell International, Inc.

11.3. Cordlife

11.4. Cryo-Save AG

11.5. Global Cord Blood Corporation

11.6. Americord Registry LLC

11.7. Smart Cells International Ltd

11.8. Celgene Corporation

11.9. BrainStorm Cell Therapeutics

11.10. Regrow Biosciences Pvt. Ltd

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL STEM CELL BANKING MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL STEM CELL BANKING MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL STEM CELL BANKING MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL STEM CELL BANKING MARKET, BY BANK TYPE, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL STEM CELL BANKING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 7 GLOBAL STEM CELL BANKING MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: STEM CELL BANKING MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2020-2027 (USD MILLION)

TABLE 10 NORTH AMERICA: STEM CELL BANKING MARKET, BY BANK TYPE, 2020-2027 (USD MILLION)

TABLE 11 NORTH AMERICA: STEM CELL BANKING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 12 US: STEM CELL BANKING MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)

TABLE 13 US: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2020-2027 (USD MILLION)

TABLE 14 US: STEM CELL BANKING MARKET, BY BANK TYPE, 2020-2027 (USD MILLION)

TABLE 15 US: STEM CELL BANKING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 16 CANADA: STEM CELL BANKING MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)

TABLE 17 CANADA: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2020-2027 (USD MILLION)

TABLE 18 CANADA: STEM CELL BANKING MARKET, BY BANK TYPE, 2020-2027 (USD MILLION)

TABLE 19 CANADA: STEM CELL BANKING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 20 LATIN AMERICA: STEM CELL BANKING MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)

TABLE 21 LATIN AMERICA: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2020-2027 (USD MILLION)

TABLE 22 LATIN AMERICA: STEM CELL BANKING MARKET, BY BANK TYPE, 2020-2027 (USD MILLION)

TABLE 23 LATIN AMERICA: STEM CELL BANKING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 24 EUROPE: STEM CELL BANKING MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)

TABLE 25 EUROPE: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2020-2027 (USD MILLION)

TABLE 26 EUROPE: STEM CELL BANKING MARKET, BY BANK TYPE, 2020-2027 (USD MILLION)

TABLE 27 EUROPE: STEM CELL BANKING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 28 WESTERN EUROPE: STEM CELL BANKING MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)

TABLE 29 WESTERN EUROPE: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2020-2027 (USD MILLION)

TABLE 30 WESTERN EUROPE: STEM CELL BANKING MARKET, BY BANK TYPE, 2020-2027 (USD MILLION)

TABLE 31 WESTERN EUROPE: STEM CELL BANKING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 32 EASTERN EUROPE: STEM CELL BANKING MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)

TABLE 33 EASTERN EUROPE: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2020-2027 (USD MILLION)

TABLE 34 EASTERN EUROPE: STEM CELL BANKING MARKET, BY BANK TYPE, 2020-2027 (USD MILLION)

TABLE 35 EASTERN EUROPE: STEM CELL BANKING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC: STEM CELL BANKING MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2020-2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC: STEM CELL BANKING MARKET, BY BANK TYPE, 2020-2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC: STEM CELL BANKING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: STEM CELL BANKING MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: STEM CELL BANKING MARKET FOR UMBILICAL CORD STEM CELLS, BY TYPE, 2020-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: STEM CELL BANKING MARKET, BY BANK TYPE, 2020-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: STEM CELL BANKING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL STEM CELL BANKING MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL STEM CELL BANKING MARKET

FIGURE 4 GLOBAL STEM CELL BANKING MARKET SHARE, BY CELL TYPE, 2020 (%)

FIGURE 5 GLOBAL STEM CELL BANKING MARKET SHARE, BY BANK TYPE, 2020 (%)

FIGURE 6 GLOBAL STEM CELL BANKING MARKET SHARE, BY APPLICATION, 2020 (%)

FIGURE 7 GLOBAL STEM CELL BANKING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 AMERICAS: STEM CELL BANKING MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: STEM CELL BANKING MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: STEM CELL BANKING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: STEM CELL BANKING MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: STEM CELL BANKING MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: STEM CELL BANKING MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 CBR SYSTEMS, INC.: KEY FINANCIALS

FIGURE 16 CBR SYSTEMS, INC.: SEGMENTAL REVENUE

FIGURE 17 CBR SYSTEMS, INC.: REGIONAL REVENUE

FIGURE 18 CRYO-CELL INTERNATIONAL, INC.: KEY FINANCIALS

FIGURE 19 CRYO-CELL INTERNATIONAL, INC.: SEGMENTAL REVENUE

FIGURE 20 CRYO-CELL INTERNATIONAL, INC.: REGIONAL REVENUE

FIGURE 21 CORDLIFE: KEY FINANCIALS

FIGURE 22 CORDLIFE: SEGMENTAL REVENUE

FIGURE 23 CORDLIFE: REGIONAL REVENUE

FIGURE 24 CRYO-SAVE AG: KEY FINANCIALS

FIGURE 25 CRYO-SAVE AG: SEGMENTAL REVENUE

FIGURE 26 CRYO-SAVE AG: REGIONAL REVENUE

FIGURE 27 GLOBAL CORD BLOOD CORPORATION: KEY FINANCIALS

FIGURE 28 GLOBAL CORD BLOOD CORPORATION: SEGMENTAL REVENUE

FIGURE 29 GLOBAL CORD BLOOD CORPORATION: REGIONAL REVENUE

FIGURE 30 AMERICORD REGISTRY LLC: KEY FINANCIALS

FIGURE 31 AMERICORD REGISTRY LLC: SEGMENTAL REVENUE

FIGURE 32 AMERICORD REGISTRY LLC: REGIONAL REVENUE

FIGURE 33 SMART CELLS INTERNATIONAL LTD.: KEY FINANCIALS

FIGURE 34 SMART CELLS INTERNATIONAL LTD.: SEGMENTAL REVENUE

FIGURE 35 SMART CELLS INTERNATIONAL LTD.: REGIONAL REVENUE

FIGURE 36 CELGENE CORPORATION: KEY FINANCIALS

FIGURE 37 CELGENE CORPORATION: SEGMENTAL REVENUE

FIGURE 38 CELGENE CORPORATION: REGIONAL REVENUE

FIGURE 39 BRAINSTORM CELL THERAPEUTICS: KEY FINANCIALS

FIGURE 40 BRAINSTORM CELL THERAPEUTICS: SEGMENTAL REVENUE

FIGURE 41 BRAINSTORM CELL THERAPEUTICS: REGIONAL REVENUE

FIGURE 42 REGROW BIOSCIENCES PVT. LTD.: KEY FINANCIALS

FIGURE 43 REGROW BIOSCIENCES PVT. LTD.: SEGMENTAL REVENUE

FIGURE 44 REGROW BIOSCIENCES PVT. LTD.: REGIONAL REVENUE

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.